A team of scientists at UNSW Australia and the University of Oxford recently have made a discovery that will allow researchers to better determine how quickly HIV will return to a patient after the person has stopped receiving HIV treatment.
A recent study has revealed many Americans who travel internationally are considered to be at a greater risk for contract hepatitis A and measles.
Ansun BioPharma recently announced that it used its DAS181 to successfully treat a patient who had severe influenza and parainfluenza. Physicians used DAS181 as part of an emergency investigational new…
While at the University of Maryland (UMD) School of Medicine’s Institute of Human Virology, Maryland Lt. Gov. Boyd Rutherford announced the institute has started Phase 1 clinical trial of its new…
An immunization campaign in Timor-Leste targets children living in remote areas who have not received their vaccinations by increasing the coverage rate and the capacity of various national health institutions.
The Center for Health Protection (CHP), a branch of the Department of Health (DH), recently released the latest update about the number of dengue fever cases in Hong Kong.
A new partnership between Cipla Medpro (Pty) Ltd, a worldwide pharmaceutical company with cutting edge innovation and technology to meet patients’ needs, and Serum Institute India (SII), the world’s biggest…
GlaxoSmithKline (GSK) and Pfizer recently announced that they have successfully finalized their transaction of Nimenrix and Mencevax, both of which are meningitis assets.
Dr. Leung Ting-hung, Controller of the Center for Health Protection (CHP) of the Hong Kong Department of Health (DH), recently announced that free influenza vaccination coverage has been expanded to…
Vaxart Inc., a privately held clinical-stage biotechnology company that creates oral recombinant vaccines in the form of tablets instead of injections, recently announced that its representatives will present data from…
A large new national report about the use of neuraminidase inhibitors, or antiviral drugs, to prevent and treat influenza has used studies from The University of Nottingham to establish its…
Pharmaceutical Product Development LLC (PPD) recently announced that it has accepted two different U.S. government contracts from the U.S. Army and from BARDA to further research and develop pharmaceutical products.
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) recently provided sponsorship of two novel approaches to improving influenza vaccines.
Sign-up for the Weekly Newsletter from Vaccine News Daily.